RBFOX3 and Parkinson disease: A 6-hydroxydopamine (6-OHDA) model of PD showed an increase in the number of BrdU/NeuN-labeled cells in the striatum, but none of these co-labeled for DARPP-32 (a marker of striatal neurons; Mohapel et al., 2005).